LncRNA type | Expression | Potential target(s) | Pathways | References |
---|---|---|---|---|
LET | Downregulated | NA | ↓Cell proliferation, invasion and tumor growth; ↑apoptosis; G0/G1 arrest | [10] |
LINC00152 | Upregulated | miR-138 | ↑Cell proliferation, migration, invasion and EMT; ↑tumor peritoneal spreading and metastasis; ↓apoptosis; PI3K/AKT pathway; LINC00152/miR-138/HIF-1α pathway | |
MEG3 | Downregulated | EZH2, LATS2 | ↓Cell proliferation, invasion, EMT and tumor growth; ↑cell apoptosis; G1/G0 arrest; ↑EZH2 ubiquitination; ↑p53; ↓CDK4 and CyclinD1 | |
ANRIL | Upregulated | NA | ↑Cell proliferation and tumor growth; ↓apoptosis; ↓p53; ↑CyclinD1 | [12] |
GCASPC | Downregulated | Pyruvate carboxylase | ↓Cell proliferation and tumor growth; ↓pyruvate carboxylase | [11] |
MALAT1 | Upregulated | miR-206 | ↑Cell proliferation and invasion; ↓cell apoptosis; ↓miR-206; ↑KRAS and annexin a2 | |
MINCR | Upregulated | miR-26a-5p | ↑Cell proliferation, EMT and invasion; ↓cell apoptosis; MINCR/miR-26a-5p/EZH2 axis | [20] |
AFAP1-AS1 | Upregulated | NA | ↑Cell proliferation, EMT and tumor invasion | [21] |
UCA1 | Upregulated | EZH2 | ↑Cell proliferation, EMT and metastasis; ↓p21 and E-cadherin | [22] |
PAGBC | Upregulated | miR-133b, miR-511 | ↑Cell proliferation, migration and invasion; ↑tumor growth and metastasis; ↑SOX4 and PIK3R3; AKT/mTOR pathway; PABPC1 | [23] |
Loc344887 | Upregulated | NA | ↑Cell proliferation, mobility, EMT and invasion | [24] |
ROR | Upregulated | NA | ↑Cell proliferation, migration, EMT and invasion | [25] |
HEGBC | Upregulated | IL-11 | ↑Cell proliferation, migration; ↑tumor growth and metastasis; IL-11/STAT3 pathway | [26] |
H19 | Upregulated | AKT2 | ↑Cell proliferation and invasion; H19/miR-194-5p/AKT2 axis | |
PVT1 | Upregulated | miR-143 | ↑Cell proliferation, migration and invasion; ↑tumor growth; ↑MMP-2 and MMP-9; PVT1/miR-143/HK2 axis | [29] |